• Fusion Pharmaceuticals is a clinical stage company focused on developing novel and targeted alpha therapeutics for the treatment of cancer.

    Seroba Contact: Alan O'Connell
    Country: Canada, Ireland


    http://fusionpharma.com/
  • Endotronix is developing an implantable pulmonary artery pressure sensor and integrated patient management platform to provide comprehensive management tools for heart failure patients.

    Seroba Contact: Jennifer McMahon
    Country: USA, Ireland


    http://endotronix.com
  • MedLumics is developing optically-guided, minimally-invasive instruments to improve the treatment of atrial fibrillation and other arrhythmias.

    Seroba Contact: Daniel O'Mahony
    Country: Spain, Ireland


    https://www.medlumics.com/en/
  • Atlantic Therapeutics has developed a CE marked, neuromuscular electrical stimulation device, Innovo™, that treats urinary and faecal incontinence in a non-invasive manner.

    Seroba Contact: Daniel O'Mahony
    Country: Ireland, UK, France, Germany


    http://www.atlantictherapeutics.com/
  • Prexton is a clinical stage biotech that is developing novel treatments for the debilitating symptoms of late stage Parkinson’s disease.

    Seroba Contact: Alan O'Connell
    Country: Switzerland, The Netherlands


    http://www.prextontherapeutics.com/
  • Opsona is developing novel antibody therapeutics targeting toll-like immune receptors for the treatment of oncology and inflammatory conditions.

    Seroba Contact: Alan O'Connell
    Country: Ireland


    http://www.opsona.com/
  • Novate Medical has developed a novel inferior vena cava filter that converts from a filter to a stent, providing protection to patients at risk of pulmonary embolism.

    Seroba Contact: Daniel O'Mahony
    Country: Ireland, UK


  • Quanta Dialysis Technologies is developing advanced haemodialysis systems for dialysis patients which can be used in the home and in the clinic.

    Seroba Contact: Peter Sandys
    Country: UK


    http://www.quantadt.com/
  • Veryan is developing innovative stent solutions which mimic the vascular system's own flow dynamics in order to treat peripheral vascular disease.

    Seroba Contact: Alan O'Connell
    Country: Ireland, UK


    http://www.veryanmed.com/
  • Apica Cardiovascular has developed novel access and closure devices for structural heart disease. Apica was acquired by Thoratec in 2014.

    Seroba Contact: Daniel O'Mahony
    Country: Ireland, USA


  • Heart Metabolics is developing a drug to treat a rare heart disorder called hypertrophic cardiomyopathy.

    Seroba Contact: Alan O'Connell
    Country: Ireland, USA


    http://www.heartmetabolics.com/
  • PQ Bypass is developing a novel vascular stent graft, ancillary tools and an innovative procedure that treats long lesions in the peripheral vasculature.

    Seroba Contact: Daniel O'Mahony
    Country: USA, Ireland


    http://pqbypass.com/
  • Ario Pharma is developing new therapeutics for the treatment of pain and type II diabetes with pharmaceutical partners.

    Seroba Contact: Alan O'Connell
    Country: UK


    http://www.ariopharma.com/
  • Xention is a cardiovascular biotech company. Its assets have now been partnered with or acquired by pharmaceutical companies.

    Seroba Contact: Alan O'Connell
    Country: UK


    http://www.xention.com/
  • Covagen was a biotech company that developed a novel platform technology for discovery and development of bispecific antibodies. The company was acquired by Janssen.

    Seroba Contact: Daniel O'Mahony
    Country: Switzerland


  • Biosensia is developing the RapiPlex, a point-of-care diagnostic platform which is capable of producing laboratory-quality results in a 10-15 minute timeframe to detect a wide number of diseases.

    Seroba Contact: Jennifer McMahon
    Country: Ireland


    http://www.biosensia.com/
  • Labcyte is developing the revolutionary Echo acoustic liquid handling technology for applications in research and drug development - Seroba's investee company Deerac Fluidics sold to Labcyte Inc. in 2008.

    Seroba Contact: Peter Sandys
    Country: USA, Ireland


    http://www.labcyte.com/
  • Alimentary Health has developed microbiome-based healthcare and nutritional products for inflammatory and other conditions.

    Seroba Contact: Peter Sandys
    Country: Ireland


    http://www.alimentaryhealth.ie/
  • Crescent Diagnostics has developed Osentia®, a commercially available diagnostic test to identify an individual's risk of developing osteoporosis.

    Seroba Contact: Alan O'Connell
    Country: UK


    https://www.osentia.co.uk
  • AGI Therapeutics was a specialty pharmaceutical company that was focused on the development and commercialisation of specialty drug products. The company did an IPO in 2006 and was subsequently acquired by Vidara Therapeutics.

    Seroba Contact: Peter Sandys
    Country: Ireland